Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies-Reference-Cited by-同舟云学术

Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies

Published:2009-09 Issue:9 Volume:15 Page:1108-1115
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Le Blanc Katarina,Barrett A. John,Schaffer Marie,Hägglund Hans,Ljungman Per,Ringdén Olle,Remberger Mats

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation;Powles;Blood,1998

2. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation;Kim;Br J Haematol,2004

3. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia;Kumar;Bone Marrow Transplant,2001

4. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation;Lee;Haematologica,2005

5. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback;Chakrabarti;Bone Marrow Transplant,2003

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection;Transplantation and Cellular Therapy;2024-08

2. Early reversal of the lymphocyte‐to‐monocyte ratio after allogeneic‐hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis;Clinical Transplantation;2023-08-29

3. Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis;Annals of Hematology;2022-12-17

4. Immune reconstitution after allogenic stem cell transplantation: An observational study in pediatric patients;Hematology, Transfusion and Cell Therapy;2022-07

5. An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes;Cytotherapy;2022-04